The primary objectives of this pilot study are to evaluate the blood levels of an investigational drug (RV2001), and to assess its overall effect on the severity of clinical signs associated with atopic dermatitis in dogs.
Diagnosing and managing neuropathic pain in dogs with spinal cord injury (SCI). The purpose of this study to monitor dogs for the development of neuropathic pain after SCI, and to test medication effects and inter-observer agreement of a technique to quantify neuropathic pain. We will correlate these results with force plate data from dogs at the same visit.
Correlation of plasma levels of a potential biomarker (CK-18) with diarrhea in dogs with mast cell tumor treated receiving toceranib (Palladia). -- The purpose of this pilot study is to determine if plasma CK18 levels can be used as a biomarker that can predict GI side effects in dogs receiving toceranib.